By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fate Therapeutics 

10931 North Torrey Pines Road
Suite 107
La Jolla  California  92037  U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
Fate Therapeutics (FATE) Announces First Patient Treated In Protmune PROTECT Clinical Trial For The Prevention Of Graft-Versus-Host Disease 1/5/2017 7:38:23 AM
Fate Therapeutics (FATE) To Webcast Conference Call Reporting Third Quarter 2016 Financial Results On November 7, 2016 11/1/2016 8:33:45 AM
Fate Therapeutics (FATE) Announces Issuance Of U.S. Patent Protecting Enhanced Hematopoietic Stem Cell Compositions 10/5/2016 7:48:21 AM
Fate Therapeutics (FATE) Receives FDA Orphan Drug Designation For Protmune In Allogeneic Hematopoietic Cell Transplantation 9/26/2016 7:35:20 AM
San Diego's Fate Therapeutics (FATE) Lands a Deal With Star Scientist to Work on Off-the-Shelf T-Cell Immunotherapies 9/8/2016 5:42:05 AM
Fate Therapeutics (FATE) To Present At The 2016 Wedbush PacGrow Healthcare Conference 8/10/2016 1:55:32 PM
Fate Therapeutics (FATE) Reports Second Quarter 2016 Financial Results 8/9/2016 8:34:27 AM
Fate Therapeutics (FATE) Announces Issuance Of U.S. Patent On Compositions Of Human Induced Pluripotent Cells 7/26/2016 7:59:36 AM
Fate Therapeutics (FATE) Announces FDA Fast Track Designation For Protmune 6/20/2016 8:12:03 AM
Fate Therapeutics (FATE) To Host Off-The-Shelf Cancer Immunotherapy Focus Session At 2016 Annual Meeting Of International Society for Stem Cell Research 6/16/2016 10:50:28 AM